Trading On margin

Vimian’s Q4 2021 Interim Report


Continued high pace of M&As in Q4

  • Revenue increased by 74.4% to €48.7 million (27.9), of which 9% organic growth

  • Adjusted EBITA amounted to €12.0 million (9.5), corresponding to an adjusted EBITA margin of 24.7% (33.9)

  • The operating result amounts to 4.1 MEUR (3.8), including elements affecting the comparability of -4.7 MEUR (-3.9).

  • Earnings per share before and after dilution amount to EUR 0.01 (0.18)

“The pace of mergers and acquisitions accelerated in the fourth quarter and revenue increased by 74% to 48.7 million euros. sales in Diagnostics”, says Dr. Fredrik Ullman, CEO of the Vimian Group.

Revenue for the full year 2021 increased by 143% to €173.3 million, including 16.5% organic growth.

“Over the full year, we recorded revenue growth of 143% to reach 173.3 million euros. Organic growth was 16.5%, ahead of our target of 15%. In 2021, we welcomed 17 new companies and entrepreneurs to Vimian, further strengthening our geographic reach. and expanding our product offering. Including all acquisitions made in 2021, we reach €214.7 million in pro forma revenue with a pro forma EBITDA of €66.8 million,” says Dr. Fredrik Ullman, CEO of the Vimian Group.

Adjusted EBITA increased to €12.0 million (9.5) in the fourth quarter with a margin of 24.7% (33.9) and to €53.5 million (23.3) on the whole year, with a margin of 30.8% (32.7).

“Adjusted EBITA for the fourth quarter was €12.0 million, which corresponds to a margin of 24.7 percent. The lower margin compared to the fourth quarter of the previous year reflects the investments in the organization to drive growth and enter new markets, strengthening M&A capability, creating Group Functions and consolidating acquisitions with different financial profiles Adjusted EBITA margin for the entire the year 2021 was 30.8%”, says Dr. Fredrik Ullman, CEO of the Vimian Group.

A conference call and web conference will be organized for investors, analysts and the media, today at 09:00 (CET). The conference will be held in English and will include a question-and-answer session.

To attend the conference call:
SE: +46 850 558 359
UK: +44 333 300 9262
USA: +1 646 722 4904
To attend the webcast
Related presentation materials will be available on Vimian’s website ( prior to the conference call and web conference.

For more information, please contact:

Henrik Halvorsen
[email protected]
+46 709 66 71 76

Maria Tullberg
Head of IR & Communication
[email protected]
+46 736 26 88 86

About Vimian

Vimian is a fast-growing global group of innovation-driven companies with a shared passion for making a positive impact by improving animal health. Together, we put science, technology and our customers’ needs at the center of everything we do to provide effective solutions for veterinary professionals, laboratories and pet owners around the world. We bring together pioneering and entrepreneurial companies in animal health, with the aim of creating a unique and diversified offer of the highest quality products and services. Our group covers four essential and rapidly evolving areas within animal health: specialty pharmacy, diagnostics, veterinary services and MedTech. Vimian offers individual businesses access to our networks, expertise, infrastructure and capital to accelerate innovation and growth. We are as passionate about supporting leadership within our existing businesses as we are about welcoming new partners into the Vimian family – together helping us have an even greater impact by improving animal health. Based in Stockholm, Sweden, Vimian and our family of companies reach more than 15,000 customers in more than 150 markets, employ more than 600 people, and have combined annual revenue of approximately €170 million. FNCA Sweden AB has been appointed as a certified advisor to the company, [email protected], +46 (0) 8-528 00 399. For more information, please visit:

This information is information that the Vimian Group is required to make public in accordance with the EU Market Abuse Regulation. The information was submitted for publication, through the contact persons listed above, on 2022-03-10 07:45 CET.


Vimian Q4 Report
Vimian Q4 Overview

THE SOURCE: Vimien Group

See the source version on